Objective To evaluate the effect of astragalus membranaceus (AM) in combination with taurine on coxasckievirus B3 (CVB3) murine myocarditis. Methods One hundred and sixty mice were infected with CVB3 and equally di...Objective To evaluate the effect of astragalus membranaceus (AM) in combination with taurine on coxasckievirus B3 (CVB3) murine myocarditis. Methods One hundred and sixty mice were infected with CVB3 and equally divided into four groups: normal saline (NS) treated group, AM treated group, taurine treated group and AM combined with taurine treated group. The treatment were carried out from day 1 to 7 after infection. Ten mice were extracted from each group for observing mortality within day 21 postinfection, the rests were killed and the hearts were removed on day 8 (n=15) and 21 (all survival mice), respectively. Electrocardiograph (ECG) of each mouse was analysed before infection and repeated on the day of being killed. CVB3 RNA in murine myocardium was detected by in situ hybridization and myocardial lesions were observed by light microscope. Results Mortality was lower in drug treated groups than that in NS treated group, and it was the lowest in AM combined with taurine treated group, but all the differences were not significant (P>0.05). All drug treatments reduced the incidence of abnormal ECG changes in the acute phase of infection (P<0.05, vs NS treated group), but AM combined with taurine was the most effective in reducing the incidence of abnormal ECG (P<0.05, vs other groups). AM inhibited viral replication in myocardium at the early and late stage of murine myocarditis effectively and AM combined with taurine enhanced the effect of anti virus. All drugs decreased myocardial damage (P<0.05, vs control group), and the effect of AM combined with taurine was most significant (P<0.05). Conculsion The AM combined with taurine on CVB3 murine myocarditis is more effective than that of AM or taurine.展开更多
文摘Objective To evaluate the effect of astragalus membranaceus (AM) in combination with taurine on coxasckievirus B3 (CVB3) murine myocarditis. Methods One hundred and sixty mice were infected with CVB3 and equally divided into four groups: normal saline (NS) treated group, AM treated group, taurine treated group and AM combined with taurine treated group. The treatment were carried out from day 1 to 7 after infection. Ten mice were extracted from each group for observing mortality within day 21 postinfection, the rests were killed and the hearts were removed on day 8 (n=15) and 21 (all survival mice), respectively. Electrocardiograph (ECG) of each mouse was analysed before infection and repeated on the day of being killed. CVB3 RNA in murine myocardium was detected by in situ hybridization and myocardial lesions were observed by light microscope. Results Mortality was lower in drug treated groups than that in NS treated group, and it was the lowest in AM combined with taurine treated group, but all the differences were not significant (P>0.05). All drug treatments reduced the incidence of abnormal ECG changes in the acute phase of infection (P<0.05, vs NS treated group), but AM combined with taurine was the most effective in reducing the incidence of abnormal ECG (P<0.05, vs other groups). AM inhibited viral replication in myocardium at the early and late stage of murine myocarditis effectively and AM combined with taurine enhanced the effect of anti virus. All drugs decreased myocardial damage (P<0.05, vs control group), and the effect of AM combined with taurine was most significant (P<0.05). Conculsion The AM combined with taurine on CVB3 murine myocarditis is more effective than that of AM or taurine.
